SEC Form 4 · accession 0001127602-17-020197
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terence M Berge
Officer — VP Corp. Treasurer
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 11:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | M | 600 | $0.00 | A | 17,137 | D | |
| Common Stock | Jun 1, 2017 | F | 222 | $51.90 | D | 16,915 | D | |
| Common Stock | Jun 1, 2017 | M | 800 | $0.00 | A | 17,715 | D | |
| Common Stock | Jun 1, 2017 | F | 296 | $51.90 | D | 17,419 | D | |
| Common Stock | Jun 1, 2017 | M | 800 | $0.00 | A | 18,219 | D | |
| Common Stock | Jun 1, 2017 | F | 296 | $51.90 | D | 17,923 | D | |
| Common Stock | Jun 1, 2017 | M | 520 | $0.00 | A | 18,443 | D | |
| Common Stock | Jun 1, 2017 | F | 193 | $51.90 | D | 18,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Jun 1, 2017 | M | 600 | D | — | Jun 1, 2020 | Common Stock | 600 | 0 | D |
| Rsus (restricted Stock Units)F2 | $0.00 | Jun 1, 2017 | M | 800 | D | — | Jun 1, 2022 | Common Stock | 800 | 0 | D |
| Rsus (restricted Stock Units)F2 | $0.00 | Jun 1, 2017 | M | 800 | D | — | Jun 1, 2023 | Common Stock | 800 | 800 | D |
| Rsus (restricted Stock Units)F2 | $0.00 | Jun 1, 2017 | M | 520 | D | — | Jun 1, 2024 | Common Stock | 520 | 1,040 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.